Open access
Open access
Powered by Google Translator Translator

Nephrology

[Abstract Only] Randomized trial: Antibiotics vs. no therapy in kidney transplant recipients with asymptomatic bacteriuria

11 Sep, 2020 | 01:10h | UTC

Antibiotics versus no therapy in kidney transplant recipients with asymptomatic bacteriuria (BiRT): a pragmatic, multicentre, randomised controlled trial – Clinical Microbiology and Infection

 

Commentary on Twitter

 


Podcast: Hyponatremia deconstructed

8 Sep, 2020 | 01:01h | UTC

REBOOT #48 Hyponatremia Deconstructed – The Curbsiders Internal Medicine Podcast

 


[Abstract Only] Randomized trial: Drug-coated balloons for dysfunctional dialysis arteriovenous fistulas

20 Aug, 2020 | 09:13h | UTC

Drug-Coated Balloons for Dysfunctional Dialysis Arteriovenous Fistulas – New England Journal of Medicine

 


Podcast on acute kidney injury: myths & musings

21 Jul, 2020 | 08:59h | UTC

#226 Kidney Boy on Acute Kidney Injury: Myths & Musings – The Curbsiders Internal Medicine Podcast

 


[Abstract Only] Randomized trial: timing of initiation of renal-replacement therapy in acute kidney injury

16 Jul, 2020 | 08:18h | UTC

Timing of Initiation of Renal-Replacement Therapy in Acute Kidney Injury – New England Journal of Medicine

Related: Delayed versus early initiation of renal replacement therapy for severe acute kidney injury: a systematic review and individual patient data meta-analysis of randomised clinical trials – The Lancet

 


Review: Extrapulmonary Manifestations of COVID-19

13 Jul, 2020 | 00:28h | UTC

Extrapulmonary manifestations of COVID-19 – Nature Medicine

Related review: Extra‐pulmonary complications of COVID‐19: a multi‐system disease? – Journal of Medical Virology

 


Podcast: Acute Kidney Injury Caused by Proton Pump Inhibitors

12 Jul, 2020 | 23:55h | UTC

Acute Kidney Injury Caused by Proton Pump Inhibitors – JAMA

 


Microhematuria: AUA/SUFU Guideline

2 Jul, 2020 | 08:38h | UTC

Microhematuria: AUA/SUFU Guideline – American Urological Association

News Release: Leading Organizations Release Joint Clinical Guideline For Diagnosis And Evaluation Of Microhematuria – American Urological Association

 


Guideline Summary: Major Consensus Statement on IV Contrast Nephropathy

1 Jul, 2020 | 07:33h | UTC

Major Consensus Statement on IV Contrast Nephropathy – Journal Feed

Original Guideline: ACR/NKF Consensus Statement: “The Risk of Acute Kidney Injury Developing in Patients with Reduced Kidney Function Following Exposure to Intravenous Iodinated Contrast Media has Been Overstated” (Guideline and commentaries)

 


[Abstract Only] Randomized Trial: Serum Urate Lowering with Allopurinol Does Not Improve Kidney Function in Type 1 Diabetes

26 Jun, 2020 | 09:03h | UTC

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes – New England Journal of Medicine

Commentaries: Despite Lowering Serum Urate Levels, Allopurinol Does Not Slow Kidney Decline in Type 1 Diabete – Physician`s Weekly AND Does Lowering Uric Acid With Allopurinol Slow Progression Of Chronic Kidney Disease? – MedicalResearch.com AND Study finds promising treatment to slow kidney disease doesn’t prove out in clinical trial – University of Minnesota Medical School

 


AHA/AMA Joint Policy Statement: Self-Measured Blood Pressure Monitoring at Home

23 Jun, 2020 | 08:24h | UTC

Self-Measured Blood Pressure Monitoring at Home: A Joint Policy Statement from the American Heart Association and American Medical Association – Circulation

News Release: American Heart Association and American Medical Association urge broader adoption of self-measured blood pressure monitoring – American Medical Association

 


Review: Acute Kidney Injury in Critically ill Patients with COVID-19

15 Jun, 2020 | 03:41h | UTC

Acute kidney injury in critically ill patients with COVID-19 – Intensive Care Medicine

 


Characterization of Acute Kidney Injury in Critically Ill Patients with Severe Coronavirus Disease 2019

9 Jun, 2020 | 04:41h | UTC

Characterization of acute kidney injury in critically ill patients with severe coronavirus disease 2019 – Clinical Kidney Journal

Commentary: Acute kidney disease in critically ill COVID-19 patients – ERA-EDTA

 


Unruptured Intracranial Aneurysms: Pathogenesis and Individualized Management

1 Jun, 2020 | 03:39h | UTC

Unruptured Intracranial Aneurysms: Pathogenesis and individualized management – Deutsches Ärzteblatt International

 


[Abstract Only] Study: Primary Aldosteronism Common and Largely Unrecognized in Patients with Hypertension

1 Jun, 2020 | 03:41h | UTC

The Unrecognized Prevalence of Primary Aldosteronism: A Cross-sectional Study – Annals of Internal Medicine (link to abstract – $ for full-text)

Commentary: Aldosterone production is a common and unrecognized cause of high blood pressure – American College of Physicians

 


A Deep Learning Algorithm to Detect Chronic Kidney Disease from Retinal Photographs

29 May, 2020 | 03:02h | UTC

A deep learning algorithm to detect chronic kidney disease from retinal photographs in community-based populations – The Lancet Digital Health

Commentary: Opportunistic deep learning of retinal photographs: the window to the body revisited – The Lancet Digital Health

 

Related Commentary on Twitter

 


Meta-Analysis: ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19

20 May, 2020 | 09:50h | UTC

ACEI/ARB Use and Risk of Infection or Severity or Mortality of COVID-19: A Systematic Review and Meta-analysis – Pharmacological Research

Related Study (Preprint): Association of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers with the Risk of Hospitalization and Death in Hypertensive Patients with Coronavirus Disease-19 – medRxiv

 


Management of Acute Kidney Injury in Patients with COVID-19

19 May, 2020 | 04:40h | UTC

Management of acute kidney injury in patients with COVID-19 – The Lancet Respiratory Medicine

Related: Acute Kidney Injury In Patients Hospitalized With Covid-19 – Kidney International

 


New NICE Covid-19 Rapid Guidelines: Chronic Kidney Disease & Interstitial Lung Disease

18 May, 2020 | 02:15h | UTC

COVID-19 rapid guideline: chronic kidney disease – National Institute for Health and Care Excellence

COVID-19 rapid guideline: interstitial lung disease – National Institute for Health and Care Excellence

See also: Complete Collection of Covid-19 Rapid Guidelines

 


Meta-Analysis: Furosemide Stress Test as a Predictive Marker of Acute Kidney Injury Progression or Renal Replacement Therapy

11 May, 2020 | 00:12h | UTC

Furosemide stress test as a predictive marker of acute kidney injury progression or renal replacement therapy: a systemic review and meta-analysis – Critical Care

 


NICE COVID-19 Guideline: Acute Kidney Injury in Hospital

7 May, 2020 | 09:30h | UTC

COVID-19 rapid guideline: acute kidney injury in hospital – National Institute for Health and Care Excellence

 


Cohort Study: SLGT2 Inhibitors Linked to Lower Risk of Renal Events in Patients with Type 2 Diabetes

7 May, 2020 | 08:57h | UTC

Use of sodium-glucose co-transporter 2 inhibitors and risk of serious renal events: Scandinavian cohort study – The BMJ

Editorial: SGLT2 inhibitors and kidney outcomes in the real world

Commentary: Certain diabetes drugs may protect against serious kidney problems – The BMJ

Related Analysis: Communicating emerging risks of SGLT2 inhibitors—timeliness and transparency of medicine regulators – The BMJ

 


2020 International Society of Hypertension Global Hypertension Practice Guidelines

7 May, 2020 | 09:00h | UTC

2020 International Society of Hypertension Global Hypertension Practice Guidelines – Hypertension

 


New Observational Studies Confirm the Safety of Renin–Angiotensin–Aldosterone System Blockers in Patients with Covid-19

3 May, 2020 | 22:32h | UTC

Editorial: Inhibitors of the Renin–Angiotensin–Aldosterone System and Covid-19 – New England Journal of Medicine

Study 1: Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19 – New England Journal of Medicine

Study 2: Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19 – New England Journal of Medicine

Study 3: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19 – New England Journal of Medicine

Study 4: Effects Of ARBs And ACEIs On Virus Infection, Inflammatory Status And Clinical Outcomes In COVID-19 Patients With Hypertension: A Single Center Retrospective Study – Hypertension

Commentary: Blood Pressure Drugs Don’t Increase Coronavirus Risk, Studies Find – The New York Times

See also: Observational Study: Renin-Angiotensin System Inhibitors are Not Associated with Severity or Mortality in Hospitalized Patients with Coronavirus Disease (2 other studies on the subject)

 


Consensus Statement on Fundamental Concepts in Perioperative Fluid Management

30 Apr, 2020 | 03:51h | UTC

Perioperative Quality Initiative (POQI) consensus statement on fundamental concepts in perioperative fluid management: fluid responsiveness and venous capacitance – Perioperative Medicine

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.